Agency Forms Undergoing Paperwork Reduction Act Review, 34588-34589 [2018-15524]
Download as PDF
<![CDATA[
34588
Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
responses per
respondent
Number of
respondents
Form name
Average
burden per
response
(in hours)
Total burden
(in hours)
Vector control tools questionnaire .......................
Specimen collection .............................................
Total ........................
600
2,996
1
1
25/60
5/60
250
250
..............................................................................
........................
........................
........................
2,416
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–15529 Filed 7–19–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–18TH]
daltland on DSKBBV9HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessment of
a Preventive Service Program in the
Context of a Zika Virus Outbreak in
Puerto Rico’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 30,
2018 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
VerDate Sep<11>2014
18:06 Jul 19, 2018
Jkt 244001
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Assessment of a Preventive Service
Program in the Context of a Zika Virus
Outbreak in Puerto Rico—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Puerto Rico has reported the highest
number of Zika virus infections in the
United States, including infections in
pregnant women. Zika virus infection
during pregnancy has been identified as
a cause of microcephaly and other
severe brain abnormalities, and has been
linked to other problems such as
miscarriage, stillbirth, defects of the eye,
hearing deficits, limb abnormalities, and
impaired growth. One strategy to
prevent these devastating outcomes is to
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
prevent unintended pregnancy among
women at risk of Zika virus infection.
To this end, an initiative was launched
in April 2016 to train physicians at
clinics across Puerto Rico to provide
patient-centered services to women who
chose to delay or avoid pregnancy
during the Zika virus outbreak.
As part of the public health response
to the Zika virus outbreak, CDC seeks to
assess approaches to mitigating the
effects of Zika virus infection and
determine which approaches have
utility. Previous assessment of the
prevention program indicated high
satisfaction of patients with program
services. The specific objectives of this
data collection are to assess (1)
prevention strategy adherence among
patients at approximately 18 months
after receipt of program services; and (2)
prevention strategy adherence, patient
satisfaction, and unmet need for
services among participants at
approximately 30 months after receipt
of program services. The practical utility
of the information to be collected as part
of this project is to assess services
delivered to women in Puerto Rico,
monitor outcomes of interest, and
determine potential for replication/
adaptation in other jurisdictions
similarly affected by the Zika virus or
during other emergency responses. For
the information collection, CDC plans to
conduct online surveys with 1,920
patients approximately 18 months after
receiving program services and 1,760
patients approximately 30 months after
receiving program services. The number
of patients surveyed is based on an
initial sample of 3,200 patients invited
to participate, anticipating a 60%
response rate at 18 months and a 55%
response rate at 30 months.
Participation in all data collection
activities will be completely voluntary.
OMB approval is requested for two
years. Total Annualized Burden Hours
are estimated to be 259, and there are no
costs to respondents other than their
time.
E:\FR\FM\20JYN1.SGM
20JYN1
34589
Federal Register / Vol. 83, No. 140 / Friday, July 20, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Type of respondents
Form name
Patients aged 18 years or older .....................
Patients aged 18 years or older who completed 18 mo survey.
Patients aged 18 years or older who did not
complete 18 mo survey.
Online surveys (18-month follow-up) .............
Online surveys (30-month follow-up) .............
960
660
1
1
7/60
10/60
Online surveys (30-month follow-up) .............
220
1
10/60
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–15524 Filed 7–19–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–1091]
daltland on DSKBBV9HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Using
Qualitative Methods to Understand
Issues in HIV Prevention, Care and
Treatment in the United States’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 13, 2018 to obtain
comments from the public and affected
agencies. CDC received four comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
18:06 Jul 19, 2018
Jkt 244001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Using Qualitative Methods to
Understand Issues in HIV Prevention,
Care and Treatment in the United States
(OMB No. 0920–1091; expires December
31, 2018)—Extension—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The CDC’s National Center on HIV/
AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Division of
HIV/AIDS Prevention (DHAP) seeks a
three year extension for an existing
Generic information collection request
(Generic ICR) entitled, ‘‘Using
Qualitative Methods to Understand
Issues in HIV Prevention, Care and
Treatment in the United States’’ (OMB
Number: 0920–1091). Specific studies
conducted under this extended Generic
ICR will be consistent with the national
HIV prevention goals, the CDC Division
of HIV/AIDS Prevention (DHAP)
Strategic Plan, and DHAP’s High-impact
HIV Prevention approach.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
The purposes for each data collection
study supported under this extended
Generic ICR will be to understand
specific barriers and facilitators to local
HIV prevention, care and treatment in
the United States and territories. For
example, each study will seek to
identify ways to improve programmatic
activities along the continuum of HIV
prevention, treatment and care for
different populations residing in
different geographic settings with
greatest burden of HIV.
The target populations for studies
included in this extended Generic ICR
include, but are not limited to: Persons
living with HIV who are in treatment;
persons living with HIV who are out of
treatment and who may or may not be
seeking treatment at healthcare
facilities; persons at high risk for HIV
acquisition (HIV negative) and HIV
transmission (HIV positive); persons
from groups at high risk for HIV
including gay, bisexual and other MSM,
transgender persons, and injection and
non-injection drug users; persons from
racial and ethnic minorities; and
healthcare providers or other
professionals who provide HIV
prevention, care and treatment services.
Other populations may include
individuals who provide non-HIV
services or otherwise interact with
persons living with HIV or persons at
risk for HIV acquisition.
Studies will only provide local
contextual information about the
barriers and facilitators to HIV
prevention, care, and treatment
experienced by specific communities at
risk for acquiring HIV infection, by HIVpositive persons across the HIV care
continuum, and by organizations or
individuals providing HIV prevention,
care, treatment, and related support
services.
Data collection methods used in any
of the specific studies primarily will
consist of rapid qualitative assessment
methodologies, such as semi-structured
and in-depth qualitative interviews,
focus groups; direct observations;
document reviews; and short structured
surveys. Data will be analyzed using
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 83, Number 140 (Friday, July 20, 2018)]
[Notices]
[Pages 34588-34589]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15524]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-18TH]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Assessment of a Preventive Service Program
in the Context of a Zika Virus Outbreak in Puerto Rico'' to the Office
of Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on March 30, 2018 to obtain comments from the
public and affected agencies. CDC received one non-substantive comment
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Assessment of a Preventive Service Program in the Context of a Zika
Virus Outbreak in Puerto Rico--New--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Puerto Rico has reported the highest number of Zika virus
infections in the United States, including infections in pregnant
women. Zika virus infection during pregnancy has been identified as a
cause of microcephaly and other severe brain abnormalities, and has
been linked to other problems such as miscarriage, stillbirth, defects
of the eye, hearing deficits, limb abnormalities, and impaired growth.
One strategy to prevent these devastating outcomes is to prevent
unintended pregnancy among women at risk of Zika virus infection. To
this end, an initiative was launched in April 2016 to train physicians
at clinics across Puerto Rico to provide patient-centered services to
women who chose to delay or avoid pregnancy during the Zika virus
outbreak.
As part of the public health response to the Zika virus outbreak,
CDC seeks to assess approaches to mitigating the effects of Zika virus
infection and determine which approaches have utility. Previous
assessment of the prevention program indicated high satisfaction of
patients with program services. The specific objectives of this data
collection are to assess (1) prevention strategy adherence among
patients at approximately 18 months after receipt of program services;
and (2) prevention strategy adherence, patient satisfaction, and unmet
need for services among participants at approximately 30 months after
receipt of program services. The practical utility of the information
to be collected as part of this project is to assess services delivered
to women in Puerto Rico, monitor outcomes of interest, and determine
potential for replication/adaptation in other jurisdictions similarly
affected by the Zika virus or during other emergency responses. For the
information collection, CDC plans to conduct online surveys with 1,920
patients approximately 18 months after receiving program services and
1,760 patients approximately 30 months after receiving program
services. The number of patients surveyed is based on an initial sample
of 3,200 patients invited to participate, anticipating a 60% response
rate at 18 months and a 55% response rate at 30 months.
Participation in all data collection activities will be completely
voluntary. OMB approval is requested for two years. Total Annualized
Burden Hours are estimated to be 259, and there are no costs to
respondents other than their time.
[[Page 34589]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Patients aged 18 years or older....... Online surveys (18-month 960 1 7/60
follow-up).
Patients aged 18 years or older who Online surveys (30-month 660 1 10/60
completed 18 mo survey. follow-up).
Patients aged 18 years or older who Online surveys (30-month 220 1 10/60
did not complete 18 mo survey. follow-up).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-15524 Filed 7-19-18; 8:45 am]
BILLING CODE 4163-18-P
